MAIN


©1996-2019.  All Rights Reserved. Online Journal of Bioinformatics . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the  before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking: To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


OJBTM

Online Journal of Bioinformatics ©

Volume 17(1):29-40, 2016


In silico agonist for human extracellular superoxide dismutase SOD3

 

Kanipakam Hema, Sandeep Swargam, Natarajan Pradeep and Amineni Umamaheswari,

 

SVIMS Bioinformatics Centre, SVIMS University, Tirupati  India

 

ABSTRACT

 

Hema K, Swargam S, Pradeep N, Umamaheswari A., In silico agonist for human extracellular superoxide dismutase SOD3,  Onl J Bioinform., 17(1):29-40, 2016.  We describe in silico agonists of human SOD3 with predicted active site residues. Structural analysis of human SOD3 retrieved from protein data bank was followed by high-throughput virtual screening. Multi-level molecular docking studies and Prime/MM–GBSA was used to calculate binding free energy (ΔG). Residues Arg-185, Asn-180, Asn-115, His-113 of human SOD3-lead 1 docking complex formed four hydrogen bonds and Arg-186 showed one π-cation interaction with lead 1. Residues His-113, His-124, Asn-180 and Arg-186 formed in the human SOD3 lead 1 docking complex. Lead 1 had binding affinity XP GScore -7.557 kcal/mol and free binding energy ΔG score -34.20 kcal/mol with binding orientation to human SOD3 greater than existing activators. Activation of SOD3 with lead 1 may reduce oxidative stress and endothelial damage.

 

Key words: Cardiovascular diseases, SOD3, Lead 1, Docking scores, Prime/MM–GBSA.


MAIN

 

FULL-TEXT(SUBSCRIPTION OR PURCHASE TITLE $25USD)